Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States.

[1]  Anas M. Saad,et al.  Trends in Renal‐Cell Carcinoma Incidence and Mortality in the United States in the Last 2 Decades: A SEER‐Based Study , 2019, Clinical genitourinary cancer.

[2]  D. Zou,et al.  miRNA-21 and miRNA-223 expression signature as a predictor for lymph node metastasis, distant metastasis and survival in kidney renal clear cell carcinoma , 2018, Journal of Cancer.

[3]  E. Arias,et al.  Mortality in the United States, 2016. , 2017, NCHS data brief.

[4]  B. Shuch,et al.  Advances in the diagnosis of hereditary kidney cancer: Initial results of a multigene panel test , 2017, Cancer.

[5]  K. Inamura.  Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification , 2017, International journal of molecular sciences.

[6]  Brian M. Owens.  Kidney cancer , 2016, Nature.

[7]  Hong Zheng,et al.  Prediction and diagnosis of renal cell carcinoma using nuclear magnetic resonance-based serum metabolomics and self-organizing maps , 2016, Oncotarget.

[8]  Holger Moch,et al.  The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours. , 2016, European urology.

[9]  L. Fazli,et al.  DHH is an independent prognosticator of oncologic outcome of clear cell renal cell carcinoma. , 2014, The Journal of urology.

[10]  Alexandra Wollum,et al.  Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. , 2014, JAMA.

[11]  Alexander D. Romaschin,et al.  Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma , 2014, Oncotarget.

[12]  C. Porta.  How to identify active novel agents in rare cancers and then make them available: a need for a paradigm shift. , 2012, European urology.

[13]  E. Mikros,et al.  (1)H NMR metabonomic analysis in renal cell carcinoma: a possible diagnostic tool. , 2010, Journal of proteome research.

[14]  Wong-Ho Chow,et al.  Epidemiology and risk factors for kidney cancer , 2010, Nature Reviews Urology.

[15]  Benjamin Caballero,et al.  Will All Americans Become Overweight or Obese? Estimating the Progression and Cost of the US Obesity Epidemic , 2008, Obesity.

[16]  Yiran Huang,et al.  Metabonomic profiling of renal cell carcinoma: high-resolution proton nuclear magnetic resonance spectroscopy of human serum with multivariate data analysis. , 2008, Analytica chimica acta.

[17]  Jigneshkumar L Patel,et al.  Applications of artificial neural networks in medical science. , 2007, Current clinical pharmacology.

[18]  F. Guillé,et al.  Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma. , 2007, European urology.

[19]  A. Valéri,et al.  Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survival. , 2007, European urology.

[20]  J. Bongaarts.  How Long Will We Live , 2006 .

[21]  Antonio Lopez-Beltran,et al.  2004 WHO classification of the renal tumors of the adults. , 2006, European urology.

[22]  C. Wood,et al.  Young age is an independent prognostic factor for survival of sporadic renal cell carcinoma. , 2004, The Journal of urology.

[23]  P. Selby,et al.  Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility. , 2003, Cancer research.

[24]  J. Wilmoth.  Demography of longevity: past, present, and future trends , 2000, Experimental Gerontology.

[25]  P. Godley,et al.  Renal cell carcinoma. , 2002, Current opinion in oncology.